Guidance for Industry on Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use--Small Entity Compliance Guide

This Other document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder


Content

See attached file(s)

Attachments

 (1)

Guidance for Industry on Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the...

View Attachment:
Authors: cder; organ-specific; internal analgesic; antipyretic
 

 
 
Comment Period Closed
ID: FDA-2010-D-0404-0002

Document Information

Date Posted: Aug 17, 2010
Show More Details  

Comments

0
Comments Received*

Docket Information

This document is contained in
Related Dockets:
None
Related RINs: None

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.